Cambridge Cognition Holdings Plc (AIM:COG)
36.50
0.00 (0.00%)
Apr 17, 2026, 3:01 PM GMT
AIM:COG Revenue
In the year 2025, Cambridge Cognition Holdings had annual revenue of 9.40M GBP, down -9.11%. Cambridge Cognition Holdings had revenue of 5.09M in the half year ending December 31, 2025, a decrease of -31.98%.
Revenue
9.40M
Revenue Growth
-9.11%
P/S Ratio
1.81
Revenue / Employee
111.90K
Employees
84
Market Cap
16.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.40M | -942.00K | -9.11% |
| Dec 31, 2024 | 10.34M | -3.17M | -23.48% |
| Dec 31, 2023 | 13.52M | 902.00K | 7.15% |
| Dec 31, 2022 | 12.61M | 2.52M | 24.96% |
| Dec 31, 2021 | 10.09M | 3.35M | 49.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Inspiration Healthcare Group | 45.20M |
| RUA Life Sciences | 4.46M |
| CelLBxHealth | 2.62M |
| Fusion Antibodies | 1.60M |
Cambridge Cognition Holdings News
- 2 months ago - IHG revenues up, ITM Power upgrades outlook and Debenhams funding round - The Armchair Trader
- 2 months ago - Cambridge Cognition’s India deal could be a game changer - The Armchair Trader
- 8 months ago - AIM Market Roundup: Cambridge Cognition, Karelian Diamonds, Conroy Gold - The Armchair Trader
- 1 year ago - Small Cap Stocks: Quantum Blockchain, Arkle Resources, Chariot O&G - The Armchair Trader